Canada
· Delayed Price · Currency is CAD Crescita Therapeutics Statistics
Total Valuation
TSX:CTX has a market cap or net worth of CAD 9.69 million. The enterprise value is 1.87 million.
| Market Cap | 9.69M |
| Enterprise Value | 1.87M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CTX has 19.01 million shares outstanding. The number of shares has decreased by -4.25% in one year.
| Current Share Class | 19.01M |
| Shares Outstanding | 19.01M |
| Shares Change (YoY) | -4.25% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 12.99% |
| Owned by Institutions (%) | 0.79% |
| Float | 16.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.53 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.29 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.61 |
| EV / Sales | 0.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.69 |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.36 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.18 |
| Interest Coverage | -57.95 |
Financial Efficiency
Return on equity (ROE) is -18.52% and return on invested capital (ROIC) is -12.25%.
| Return on Equity (ROE) | -18.52% |
| Return on Assets (ROA) | -9.33% |
| Return on Invested Capital (ROIC) | -12.25% |
| Return on Capital Employed (ROCE) | -22.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.24% in the last 52 weeks. The beta is 1.24, so TSX:CTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +17.24% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 32.08 |
| Average Volume (20 Days) | 9,926 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CTX had revenue of CAD 18.12 million and -3.06 million in losses. Loss per share was -0.16.
| Revenue | 18.12M |
| Gross Profit | 8.94M |
| Operating Income | -3.42M |
| Pretax Income | -3.07M |
| Net Income | -3.06M |
| EBITDA | -2.51M |
| EBIT | -3.42M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 8.54 million in cash and 718,000 in debt, giving a net cash position of 7.82 million or 0.41 per share.
| Cash & Cash Equivalents | 8.54M |
| Total Debt | 718,000 |
| Net Cash | 7.82M |
| Net Cash Per Share | 0.41 |
| Equity (Book Value) | 14.87M |
| Book Value Per Share | 0.78 |
| Working Capital | 8.97M |
Cash Flow
In the last 12 months, operating cash flow was 1.83 million and capital expenditures -2.16 million, giving a free cash flow of -329,000.
| Operating Cash Flow | 1.83M |
| Capital Expenditures | -2.16M |
| Free Cash Flow | -329,000 |
| FCF Per Share | -0.02 |
Margins
Gross margin is 49.36%, with operating and profit margins of -18.87% and -16.86%.
| Gross Margin | 49.36% |
| Operating Margin | -18.87% |
| Pretax Margin | -16.94% |
| Profit Margin | -16.86% |
| EBITDA Margin | -13.85% |
| EBIT Margin | -18.87% |
| FCF Margin | n/a |
Dividends & Yields
TSX:CTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.25% |
| Shareholder Yield | 4.25% |
| Earnings Yield | -31.53% |
| FCF Yield | -3.39% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |